Bispecific antibodies in NHL: current insights and ongoing studies

Bispecific antibodies in NHL: current insights and ongoing studies

The promise of bispecific antibodies in the treatment of NHLПодробнее

The promise of bispecific antibodies in the treatment of NHL

Dr Battiwalla on the Expanding Use of Bispecific Antibodies in NHLПодробнее

Dr Battiwalla on the Expanding Use of Bispecific Antibodies in NHL

How will bispecifics impact the treatment of NHL?Подробнее

How will bispecifics impact the treatment of NHL?

How Bispecific Antibodies WorkПодробнее

How Bispecific Antibodies Work

The role of bispecific antibodies in R/R NHL: the biology of these agents and what the future holdsПодробнее

The role of bispecific antibodies in R/R NHL: the biology of these agents and what the future holds

The role of bispecific antibodies in the treatment landscape for R/R DLBCLПодробнее

The role of bispecific antibodies in the treatment landscape for R/R DLBCL

Bispecific antibodies prior to alloSCT in NHL: a retrospective multi-center analysisПодробнее

Bispecific antibodies prior to alloSCT in NHL: a retrospective multi-center analysis

Clinical guidance for the use of bispecific antibodies in NHLПодробнее

Clinical guidance for the use of bispecific antibodies in NHL

Promising agents being explored in R/R MCL: bispecific antibodies and BTK inhibitorsПодробнее

Promising agents being explored in R/R MCL: bispecific antibodies and BTK inhibitors

Bispecific Antibodies for B-cell Lymphoma Treatment | OncotargetПодробнее

Bispecific Antibodies for B-cell Lymphoma Treatment | Oncotarget

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncologyПодробнее

Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology

How Bispecific Antibodies WorkПодробнее

How Bispecific Antibodies Work

Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Epcoritamab - Blood Cancers OncTalk 2023Подробнее

Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Epcoritamab - Blood Cancers OncTalk 2023

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)Подробнее

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)

Bispecific AntibodyПодробнее

Bispecific Antibody

An insight into how bispecifics are changing the lymphoma treatment landscapeПодробнее

An insight into how bispecifics are changing the lymphoma treatment landscape

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)Подробнее

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)

Bispecifics in NHL: epcoritamab and glofitamabПодробнее

Bispecifics in NHL: epcoritamab and glofitamab

Understanding Bispecific AntibodiesПодробнее

Understanding Bispecific Antibodies